SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-024759
Filing Date
2019-07-10
Accepted
2019-07-10 16:15:58
Documents
3
Period of Report
2019-07-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - ANNUAL MEETING RESULTS sbph-8k_20190710.htm 8-K 45676
2 EX-99.1 sbph-ex991_6.htm EX-99.1 15489
3 GRAPHIC gr10adkrnjwl000001.jpg GRAPHIC 14379
  Complete submission text file 0001564590-19-024759.txt   82311
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 19949517
SIC: 2834 Pharmaceutical Preparations